Pregabalin in the management of central neuropathic pain

Bibliography

• Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. MERSKEY H, BOGDUK N (Eds), IASP Press, Seattle (1994).
   Google Scholar
• FINNERUP NB, GOTTRUP H, JENSEN TS: Anticonvulsants in central pain. Expert Opin. Pharmacother. (2002) 3(10):1411-1420.
   PubMedGoogle Scholar
• FRESE A, HUSSTEDT IW, RINGELSTEIN EB, EVERS S: Pharmacologic treatment of central post-stroke pain. Clin. J. Pain (2006) 22(3):252-260.
   PubMed Web of Science ®Google Scholar
• FINNERUP NB, OTTO M, MCQUAY HJ, JENSEN TS, SINDRUP SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain (2005) 118(3):289-305.
   PubMed Web of Science ®Google Scholar
• TIIPPANA EM, HAMUNEN K, KONTINEN VK, KALSO E: Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth. Analg. (2007) 104(6):1545-1556.
   PubMed Web of Science ®Google Scholar
• TAYLOR CP, ANGELOTTI T, FAUMAN E: Pharmacology and mechanism of action of pregabalin: the calcium channel α2-δ subunit as a target for antiepileptic drug discovery. Epilepsy Res. (2007) 73(2):137-150.
   PubMed Web of Science ®Google Scholar
• TASSONE DM, BOYCE E, GUYER J, NUZUM D: Pregabalin: a novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin. Ther. (2007) 29(1):26-48.
   PubMed Web of Science ®Google Scholar
• SONNETT TE, SETTER SM, CAMPBELL RK: Pregabalin for the treatment of painful neuropathy. Expert Rev. Neurother. (2006) 6(11):1629-1635.
   PubMedGoogle Scholar
• MONTGOMERY SA: Pregabalin for the treatment of generalised anxiety disorder. Expert Opin. Pharmacother. (2006) 7(15):2139-2154.
   PubMed Web of Science ®Google Scholar
• FRAMPTON JE, FOSTER RH: Pregabalin: in the treatment of postherpetic neuralgia. Drugs (2005) 65(1):111-118; discussion 119-120.
   PubMed Web of Science ®Google Scholar
• FRAMPTON JE, FOSTER RH: Pregabalin: in the treatment of generalised anxiety disorder. CNS Drugs (2006) 20(8):685-693; discussion 694-695.
   PubMed Web of Science ®Google Scholar
• FRAMPTON JE, SCOTT LJ: Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs (2004) 64(24):2813-2820; discussion 2821.
   PubMed Web of Science ®Google Scholar
• DOGGRELL SA: Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opin. Pharmacother. (2005) 6(14):2535-2539.
   PubMed Web of Science ®Google Scholar
• SHNEKER BF, MCAULEY JW: Pregabalin: a new neuromodulator with broad therapeutic indications. Ann. Pharmacother. (2005) 39(12):2029-2037.
   PubMed Web of Science ®Google Scholar
• BEN-MENACHEM E: Pregabalin pharmacology and its relevance to clinical practice. Epilepsia (2004) 45(S6):13-18.
   PubMed Web of Science ®Google Scholar
• NAMAKA M, GRAMLICH C, RUHLEN D et al.: A treatment algorithm for neuropathic pain. Clin. Ther. (2004) 26(7):951-979.
   PubMed Web of Science ®Google Scholar
• SIDDALL PJ, LOESER JD: Pain following spinal cord injury. Spinal Cord (2001) 39(2):63-73.
   PubMed Web of Science ®Google Scholar
• OSTERBERG A, BOIVIE J, THUOMAS KA: Central pain in multiple sclerosis – prevalence and clinical characteristics. Eur. J. Pain (2005) 9(5):531-542.
   PubMed Web of Science ®Google Scholar
• ROG DJ, NURMIKKO TJ, FRIEDE T, YOUNG CA: Validation and reliability of the neuropathic pain scale (NPS) in multiple sclerosis. Clin. J. Pain (2007) 23(6):473-481.
   PubMed Web of Science ®Google Scholar
• TODOR DR, MU HT, MILHORAT TH: Pain and syringomyelia: a review. Neurosurg. Focus (2000) 8(3):Article 11.
   PubMedGoogle Scholar
• ANDERSEN G, VESTERGAARD K, INGEMAN-NIELSEN M, JENSEN TS: Incidence of central post-stroke pain. Pain (1995) 61(2):187-193.
   PubMed Web of Science ®Google Scholar
• ZALETEL M, ZVAN B, KOBAL J: Influence of age on central post-stroke pain. 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• LEIJON G, BOIVIE J: Central post-stroke pain – a controlled trial of amitriptyline and carbamazepine. Pain (1989) 36(1):27-36.
   PubMed Web of Science ®Google Scholar
• VESTERGAARD K, ANDERSEN G, GOTTRUP H, KRISTENSEN BT, JENSEN TS: Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology (2001) 56(2):184-190.
   PubMed Web of Science ®Google Scholar
• CHEN B, STITIK TP, FOYE PM, NADLER SF, DELISA JA: Central post-stroke pain syndrome: yet another use for gabapentin? Am. J. Phys. Med. Rehabil. (2002) 81(9):718-720.
   PubMed Web of Science ®Google Scholar
• SIDDALL PJ, MCCLELLAND JM, RUTKOWSKI SB, COUSINS MJ: A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain (2003) 103(3):249-257.
   PubMed Web of Science ®Google Scholar
• FINNERUP N: Mechanisms of spinal cord injury pain – evidence form human studies. 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• WRIGLEY PJ, GUSTIN SM, NASH PG et al.: Structural changes associated with pain in spinal cord injured patients. 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• CARDENAS DD, WARMS CA, TURNER JA et al.: Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain (2002) 96(3):365-373.
   PubMed Web of Science ®Google Scholar
• HALLER H, LEBLHUBER F, TRENKLER J, SCHMIDHAMMER R: Treatment of chronic neuropathic pain after traumatic central cervical cord lesion with gabapentin. J. Neural Transm. (2003) 110(9):977-981.
   PubMed Web of Science ®Google Scholar
• KAPADIA NP, HARDEN N: Gabapentin for chronic pain in spinal cord injury: a case report. Arch. Phys. Med. Rehabil. (2000) 81(10):1439-1441.
   PubMed Web of Science ®Google Scholar
• NESS TJ, SAN PEDRO EC, RICHARDS JS et al.: A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. Pain (1998) 78(2):139-143.
   PubMed Web of Science ®Google Scholar
• TO TP, LIM TC, HILL ST et al.: Gabapentin for neuropathic pain following spinal cord injury. Spinal cord (2002) 40(6):282-285.
   PubMed Web of Science ®Google Scholar
• PUTZKE JD, RICHARDS JS, KEZAR L, HICKEN BL, NESS TJ: Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin. J. Pain (2002) 18(2):116-121.
   PubMed Web of Science ®Google Scholar
• AHN SH, PARK HW, LEE BS et al.: Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Spine (2003) 28(4):341-346; discussion 346-347.
   PubMed Web of Science ®Google Scholar
• LEVENDOGLU F, OGUN CO, OZERBIL O, OGUN TC, UGURLU H: Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine (2004) 29(7):743-751.
   PubMed Web of Science ®Google Scholar
• TAI Q, KIRSHBLUM S, CHEN B et al.: Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J. Spinal Cord Med. (2002) 25(2):100-105.
   PubMedGoogle Scholar
• GALER BS, JENSEN MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology (1997) 48(2):332-338.
   PubMed Web of Science ®Google Scholar
• SIDDALL PJ, MIDDLETON JW: A proposed algorithm for the management of pain following spinal cord injury. Spinal Cord (2006) 44(2):67-77.
   PubMed Web of Science ®Google Scholar
• SOLARO C, LUNARDI GL, CAPELLO E et al.: An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology (1998) 51(2):609-611.
   PubMed Web of Science ®Google Scholar
• PRAZNIKAR A: Lamotrigine in intractable trigeminal neuralgia associated with multiple sclerosis: a case report. 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• BOUHASSIRA D, ATTAL N, ALCHAAR H et al.: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain (2005) 114(1-2):29-36.
   PubMed Web of Science ®Google Scholar
• KRAUSE SJ, BACKONJA MM: Development of a neuropathic pain questionnaire. Clin. J. Pain (2003) 19(5):306-314.
   PubMed Web of Science ®Google Scholar
• BENNETT M: The LANSS pain scale: the leeds assessment of neuropathic symptoms and signs. Pain (2001) 92(1-2):147-157.
   PubMed Web of Science ®Google Scholar
• BENNETT MI, ATTAL N, BACKONJA MM et al.: Using screening tools to identify neuropathic pain. Pain (2007) 127(3):199-203.
   PubMed Web of Science ®Google Scholar
• VAN SEVENTER R, FEISTER HA, YOUNG JP Jr et al.: Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr. Med. Res. Opin. (2006) 22(2):375-384.
   PubMed Web of Science ®Google Scholar
• RICHTER RW, PORTENOY R, SHARMA U et al.: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J. Pain (2005) 6(4):253-260.
   PubMed Web of Science ®Google Scholar
• CROFFORD LJ, ROWBOTHAM MC, MEASE PJ et al.: Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. (2005) 52(4):1264-1273.
   PubMed Web of Science ®Google Scholar
• TAYLOR CP, VARTANIAN MG, YUEN PW et al.: Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. (1993) 14(1):11-15.
   PubMed Web of Science ®Google Scholar
• FIELD MJ, COX PJ, STOTT E et al.: Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. USA (2006) 103(46):17537-17542.
   PubMed Web of Science ®Google Scholar
• LUO ZD, CALCUTT NA, HIGUERA ES et al.: Injury type-specific calcium channel α2-δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. (2002) 303(3):1199-1205.
   PubMed Web of Science ®Google Scholar
• MELROSE HL, KINLOCH RA, COX PJ et al.: [3H] pregabalin binding is increased in ipsilateral dorsal horn following chronic constriction injury. Neurosci. Lett. (2007) 417(2):187-192.
   PubMed Web of Science ®Google Scholar
• KRUSZEWSKI SP, SHANE JA: Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial [comment]. Neurology (2007) 68(24):2158-2159; author reply 2159-2160.
   PubMed Web of Science ®Google Scholar
• DOOLEY DJ, TAYLOR CP, DONEVAN S, FELTNER D: Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci. (2007) 28(2):75-82.
   PubMed Web of Science ®Google Scholar
• EISENBERG E, RIVER Y, SHIFRIN A, KRIVOY N: Antiepileptic drugs in the treatment of neuropathic pain. Drugs (2007) 67(9):1265-1289.
   PubMed Web of Science ®Google Scholar
• SIDDALL PJ, COUSINS MJ, OTTE A et al.: Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology (2006) 67(10):1792-1800.
   PubMed Web of Science ®Google Scholar
• VRANKEN JH, DIJKGRAAF MG, KRUIS MR et al.: Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain (2007):Doi:10.1016/j.pain.2007.06.033.
   PubMedGoogle Scholar
• MURPHY TK, SIDDALL PJ, GRIESING T: Efficacy, by baseline severity of anxiety symptoms, of pregabalin for treating central neuropathic pain in patients with spinal cord injury (SCI). 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• MURPHY N, MOCKLER M, RYDER M, LEDWIDGE M, MCDONALD K: Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain. J. Card. Fail. (2007) 13(3):227-229.
   PubMed Web of Science ®Google Scholar
• PRILIPKO O, DELAVELLE J, SEECK M: Pregabalin-withdrawal encephalopathy and splenial edema. Ann. Neurol. (2006) 59(1):214.
   PubMed Web of Science ®Google Scholar
• TOTH C: The utility of pregabalin in neuropathic pain patients – degree of benefit in responders and non–responders to gabapentin. 2nd International Congress on Neuropathic Pain. Berlin (June 2007).
   Google Scholar
• FREYNHAGEN R, STROJEK K, GRIESING T, WHALEN E, BALKENOHL M: Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain (2005) 115(3):254-263.
   PubMed Web of Science ®Google Scholar